Gold nanoparticles against respiratory diseases: oncogenic and viral pathogens review.
Nanoscale size-dependent properties give nanomaterials unique specifications that are robust in many applications of human medicine. Gold nanoparticles (AuNPs) have recently gained attention because of their unique optical, physical and electrical properties. AuNPs increase the efficacy of biomedical applications in diagnostic treatments for infectious diseases, by targeting or labeling target cells/bioactive compounds. However, it is imperative to develop the regimens for more accurate diagnostic tools, preventive care and effective therapy. Our critical and comprehensive review presents emerging avenues of molecular diagnostics as well as therapeutics translated into clinical approaches. This manuscript critically reviews the rampant future of AuNPs in the diagnosis and treatment of the most important diseases, such as cancer and viruses of respiratory system.
['V|Raji|R|', 'Pal|Kaushik|K|', 'Zaheer|Tean|T|0000-0001-8248-6451', 'Kalarikkal|Nandakumar|N|', 'Thomas|Sabu|S|0000-0003-4726-5746', 'de Souza|Fernando Gomes|FG|', 'Si|Asiya|A|']
D000970:Antineoplastic Agents D000073640:Betacoronavirus D000086382:COVID-19 D018352:Coronavirus Infections D004337:Drug Carriers D006046:Gold D006801:Humans D008171:Lung Diseases D053768:Metal Nanoparticles D009369:Neoplasms D058873:Pandemics D010789:Phototherapy D011024:Pneumonia, Viral D000086402:SARS-CoV-2
gold nanoparticles therapeutics cancer COVID-19 coronavirus imaging plasmonic